home / stock / bntc / bntc news

BNTC News and Press, Benitec Biopharma Limited From 06/28/22

Stock Information
Company Name: Benitec Biopharma Limited
Stock Symbol: BNTC
Market: NASDAQ
Website: benitec.com
Menu
BNTC BNTC Quote BNTC Short BNTC News BNTC Articles BNTC Message Board
Get BNTC Alerts

News, Short Squeeze, Breakout and More Instantly...
BNTC - Cognyte Software, Acutus Medical, NeuroSense Therapeutics among premarket losers' pack

Cognyte Software (CGNT) -23% on Q1 earnings release. Acutus Medical (AFIB) -9%. Benitec Biopharma (BNTC) -9%. Fujian Blue Hat Interactive Entertainment Technology (BHAT) -8%. ToughBuilt Industries (TBLT) -6%. NeuroSense Therapeutics (NRSN) -6%. For further details see: Cognyte...
BNTC - Coinbase Global, Spirit Airlines, Digital World Acquisition among premarket losers' pack

Borqs Technologies (BRQS) -25% after announcing 1-for-16 reverse stock split. Benitec Biopharma (BNTC) -13%. ToughBuilt Industries (TBLT) -14%. Chimerix (CMRX) -10% Monkeypox plays are lower as WHO rules out emergency status. Fujian Blue Hat Interactive Entertainment Techn...

BNTC - Penny Stocks To Buy Now? 4 Biotech Stocks To Watch Before July 2022

There’s only one week left until we turn the page on June and the second quarter. With GDP numbers and more CPI data expected to show the progress in curbing inflation, the market’s risk appetite seems to change daily. But one of the more static trends in the stock market toda...

BNTC - Benitec GAAP EPS of -$0.40 beats by $0.04, revenue of $0.48M

Benitec press release (NASDAQ:BNTC): Q3 GAAP EPS of -$0.40 beats by $0.04. Revenue of $0.48M. For further details see: Benitec GAAP EPS of -$0.40 beats by $0.04, revenue of $0.48M

BNTC - Benitec Biopharma Releases Q3 2022 Financial Results

HAYWARD, Calif., May 16, 2022 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “the Company”), a development-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary DNA-directed RNA int...

BNTC - Benitec GAAP EPS of -$0.59, revenue of $25K

Benitec press release (NASDAQ:BNTC): FQ2 GAAP EPS of -$0.59. Revenue of $25K. For further details see: Benitec GAAP EPS of -$0.59, revenue of $25K

BNTC - Benitec Biopharma Discloses Q2 2022 Financial Results

Benitec Biopharma Discloses Q2 2022 Financial Results PR Newswire HAYWARD, Calif. , Feb. 14, 2022 /PRNewswire/ -- Benitec Biopharma Inc. (NASDAQ: BNTC) ("Benitec" or "the Company"), a development-stage, gene therapy-focused, biotechnology company developing ...
BNTC - INFI, VYNE and RSLS among premarket gainers

Context Therapeutics (NASDAQ:CNTX) +25% on positive ONA-XR data in early breast cancer study. American Virtual Cloud Technologies (NASDAQ:AVCT) +25% Kandy and Braidio announce expanded partnership to accelerate the delivery of digital transformation as a service solutions. Ener...

BNTC - Benitec Biopharma Discloses Q1 2022 Financial Results

Benitec Biopharma Discloses Q1 2022 Financial Results PR Newswire HAYWARD, Calif. , Nov. 15, 2021 /PRNewswire/ -- Benitec Biopharma Inc. (NASDAQ: BNTC) ("Benitec" or "the Company"), a development-stage, gene therapy-focused, biotechnology company developing n...

BNTC - Benitec Biopharma Provides Operational Update and Releases its 2021 Fiscal Year-End Financial Results

Benitec Biopharma Provides Operational Update and Releases its 2021 Fiscal Year-End Financial Results PR Newswire HAYWARD, Calif. , Sept. 20, 2021 /PRNewswire/ -- Benitec Biopharma Inc. (NASDAQ: BNTC) ("Benitec" or "the Company"), a development-stage, gene t...
Previous 10 Next 10